Immunoglobulins Intravenous (Human) ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
65	原発性免疫不全症候群	3

65. 原発性免疫不全症候群

---

臨床試験数 : 500 /  薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00322556 (ClinicalTrials.gov)	November 2005	5/5/2006	Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)	A Multicenter Extension Study on the Safety and Efficacy of IgPro10 in Patients With Primary Immunodeficiency (PID)	Agammaglobulinemia;IgG Deficiency;Common Variable Immunodeficiency	Drug: Immunoglobulins Intravenous (Human)	CSL Behring	NULL	Completed	4 Years	71 Years	All	55	Phase 3	United States
2	NCT00168025 (ClinicalTrials.gov)	September 2004	12/9/2005	Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)	A Multicenter Study on the Efficacy, Safety and Pharmacokinetics of IgPro10 in Patients With Primary Immunodeficiency (PID)	Agammaglobulinemia;IgG Deficiency;Common Variable Immunodeficiency	Drug: Immunoglobulins Intravenous (Human)	CSL Behring	NULL	Completed	3 Years	70 Years	Both	89	Phase 3	NULL
3	NCT00168012 (ClinicalTrials.gov)	September 2004	12/9/2005	Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)	An Open Study to Evaluate the Safety and Efficacy of IVIG-F10 in Patients With Primary Immunodeficiency Diseases (PID)	Agammaglobulinemia;IgG Deficiency;Common Variable Immunodeficiency	Drug: Immunoglobulins Intravenous (Human)	CSL Behring	NULL	Completed	3 Years	70 Years	Both	42	Phase 3	NULL